Myrtle Beach pastor John-Paul "JP" Miller was arrested Nov. 6 and charged with third-degree assault and battery after a ...

Abbott and Reckitt's unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on ...

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma ... that it will take the drug off the US market. The company said it has started the ...

The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Clene's cash, cash equivalents and marketable securities totaled $14.6 million as of September 30, 2024, compared to $35.0 million as of December 31, 2023. Clene expects that its resources as of ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...

Trading will be suspended on Nasdaq starting October 16, 2024, with Seelos expected to begin trading on the OTCQB market. There is no guarantee that the company’s common stock will continue to ...